lasofoxifene
lasofoxifene: developed by 1 company · 1 clinical trial tracked.
lasofoxifene evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
How could lasofoxifene → LONA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Development Pipeline (1)
| Company | Phase |
|---|---|
| LeonaBio, Inc. (LONA) | Phase 3 |
Clinical Trials (1)
A Double-blind, Randomized, Placebo-controlled Proof oF Concept Clinical Study to Evaluate the Safety, Pharmacokinetics, AND Pharmacodynamics of Vaginal AZU-101 (Lasofoxifene Tartrate) in Postmenopausal Women
Primary endpoint: Number of Participants Who Had Any Serious Adverse Events or Any Treatment Emergent Adverse Events With Severity Greater Than "Moderate" as measured by CTCAE v4.0
Frequently asked questions
Who is developing lasofoxifene?
lasofoxifene is being developed by LeonaBio, Inc..
How many clinical trials involve lasofoxifene?
BioSniper tracks 1 clinical trial involving lasofoxifene.